Idera Pharmaceuticals reported $52K in Ordinary Share Capital for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ordinary Share Capital Change
Aceto ACET:US 3K 0
Agenus AGEN:US $ 2.25M 0.07M
Alnylam Pharmaceuticals ALNY:US $ 1.19M 0.01M
Amgen AMGN:US $ 31877M 71M
Biogen BIIB:US $ 0.1M 0M
Biomarin Pharmaceutical BMRN:US $ 0.18M 0M
Cytrx CYTR:US 36.78K 300
Dynavax Technologies DVAX:US $ 0.11M 0M
Eli Lilly And LLY:US $ 598.1M 1.6M
GlaxoSmithKline GSK:LN 1347M 1M
Idera Pharmaceuticals IDRA:US $ 0.05M 0.01M
Mirati Therapeutics MRTX:US $ 0.05M 0M
Nektar Therapeutics NKTR:US $ 0.02M 0M
Sarepta Therapeutics SRPT:US $ 0.01M 0M
Seattle Genetics SGEN:US $ 0.18M 0M
Ultragenyx Pharmaceutical RARE:US $ 0.07M 0M